High CK18 expression in serum was remarkable relevant with poor outcome of breast cancer patients, while when high expressed in tissue, elevated level of CK18 was significantly associated with favorable prognosis of breast cancer patients. This evidence concerns the gene KRT18 and breast carcinoma.